Sign In
Log in

HSN Leadership​

Cynthia I. Campbell, PhD, MPH

Health System Network Principal Investigator
Kaiser Permanente Division of Research

Cynthia Campbell 

Dr. Cynthia Campbell is a research scientist at the Division of Research, Kaiser Permanente Northern California, conducting research on the treatment of substance use and mental health problems. She is also an Adjunct Associate Professor in the Department of Psychiatry, University of California, San Francisco. Her interests include access to treatment, chronic pain and substance use, prescription opioid use and misuse, adolescent behavioral health, benefit design and cost sharing, and organizational factors and policy related to these areas. She is currently the principal investigator of a NIDA-funded study examining the impact of the ACA on addiction and HIV services, a NIDA-funded study examining substance use service intensity for buprenorphine patients, and a PCORI-funded study of a patient activation intervention in primary care for chronic pain patients starting long-term prescription opioid use. Her work also includes the assessment of attention deficit hyperactivity disorder (ADHD) in children. She received her doctorate in Public Health at the University of Michigan, and conducted her postdoctoral work at UCSF in a NIDA-funded fellowship on Substance Abuse and Health Services.



 

 


Constance M. Weisner, DrPH, MSW

Health System Network Principal Investigator
Kaiser Permanente Division of Research

Constance Weisner 

Dr. Connie Weisner is a research scientist at the Kaiser Permanente Northern California Division of Research; and professor at the Department of Psychiatry, University of California, San Francisco. Dr. Weisner has a doctorate in public health from the University of California, Berkeley and a master's in social work from the University of Minnesota. She directs a research program addressing access, treatment outcome, and cost-effectiveness of alcohol and drug treatment in public and private settings, including managed care. Dr. Weisner is a member of the National Advisory Council of the National Institute on Drug Abuse, International Expert Advisory Group on Alcohol and Drug Dependence of the World Health Organization, and MacArthur Network on Mental Health and the Law. She has also been a member of the National Advisory Council of the Center for Substance Abuse Treatment. Dr. Weisner has participated on several Institute of Medicine committees, including the recent "Adapting 'Crossing the Quality Chasm' to Mental Health and Addictive Disorders." Dr. Weisner's published work includes studies of epidemiology of alcohol and drug problems; the interaction among alcohol, drug, mental health and medical problems; and the outcomes and cost-effectiveness of treatment services. She is the principal investigator of NIAAA, NIDA, and RWJF research grants that study the cost and effectiveness of alcohol and drug treatment interventions. Her ongoing work focuses on the changing systems for receiving health, substance abuse and mental health services.

 

 


Katharine A. Bradley, MD, MPH

Health System Network Principal Investigator
Group Health Research Institute

Katharine Bradley 

Dr. Katharine Bradley is a general internist and Senior Investigator at Group Health, conducting research that concentrates on identifying and addressing unhealthy alcohol use in primary care. Currently, Dr. Bradley is evaluating performance measures of brief alcohol counseling. She recently turned her attention to management of alcohol use disorders in primary care settings, as well as identifying and addressing drug use disorders with proactive outreach. She is leading the National Institute of Health's National Institute on Alcohol Abuse and Alcoholism Study on Collaborative Care for Primary Care Patients with unhealthy drinking: "Considering Healthier Drinking Options in Collaborative Care" (CHOICE) trial, which has finished enrollment and will be completed in October 2015. She and her clinical partners are also funded by the Agency for Health Research and Quality to implement alcohol screening, brief alcohol counseling, and shared decision-making for alcohol use disorders in a sustainable manner at all 25 primary care clinics within Group Health. In addition, she has ongoing research developing a patient decision aid for shared decision-making for alcohol use disorders, and with her clinical partners, has obtained a Group Health Partnership for Innovation grant to test proactive outreach from primary care teams to patients with alcohol or drug use disorders. 



 

 


Steering Committee

The Steering Committee is made up of all of the HSN health system site leaders, and meets monthly via teleconference, and annually in person to disseminate current SU/SUD information, generate research ideas, discuss progress on active studies, and hear and discuss NIDA CTN updates from the HSN Principal Investigators.

info@ctnhsn.org 510-891-3560     2000 Broadway, Oakland, CA 94612 | NIDA Clinical Trials Network   CTN logo

© Copyright 2017 ctnhsn.org